MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 29.07.2025
DBV Technologies S.A. Langfristiger Schuldenstrom 2011-2026 | DBVT
Langfristiger Schuldenstrom Jährlich DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654 K | 1.14 M | 1.89 M | 3 M | 3.71 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.71 M | 654 K | 2.08 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
10.2 M | $ 18.33 | -0.92 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
107 M | $ 343.48 | 0.47 % | $ 184 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 72.81 | 5.02 % | $ 9.74 B | USA |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
137 K | $ 2.72 | 4.62 % | $ 17.1 M | USA |
 |
Adagene
ADAG
|
1.18 M | $ 2.99 | 8.55 % | $ 168 M | China |
 |
Biogen
BIIB
|
86.4 M | $ 177.96 | -1.07 % | $ 25.9 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.12 | -1.74 % | $ 7.51 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
4.49 M | $ 1.4 | -0.71 % | $ 262 M | USA |
 |
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
14.2 M | $ 223.74 | -1.05 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 4.13 | 2.92 % | $ 8.99 B |  Israel |
 |
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
39.5 M | $ 110.82 | -2.58 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.39 | 1.09 % | $ 355 M |  Britain |
 |
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
710 K | $ 1.72 | -2.0 % | $ 82 M | USA |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
5.38 M | - | -15.15 % | $ 60.3 M | Britain |
 |
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
224 M | $ 14.17 | 3.55 % | $ 4.38 B | USA |
 |
Compugen Ltd.
CGEN
|
768 K | $ 1.85 | 0.27 % | $ 166 M | Israel |
 |
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | USA |
 |
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
937 K | $ 6.68 | 1.52 % | $ 1.38 B | USA |
 |
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
Beam Therapeutics
BEAM
|
13.5 M | $ 28.17 | 1.99 % | $ 2.32 B | USA |
 |
BeiGene, Ltd.
BGNE
|
17.6 M | - | 0.49 % | $ 251 B |  Cayman-islands |